Health Technology/clinical-trials

Phase III Trial Opens: Digital Chatbot vs Standard Remote Genetic Services in AYA Cancer Patients — What Clinicians Need to Know

247 Health News Editorial

·

8 Apr 2026

·

4 min read

·clinical-trials

A Phase III trial is investigating whether digital chatbot-enabled genetic services can match standard remote care in increasing genetic testing uptake among young adult cancer patients. The study could revolutionise genetic service delivery in community oncology settings.

Originally reported by ClinicalTrials.gov

References

  1. 1.Alliance for Clinical Trials in Oncology. (2024). AYA Access Study: An Enhanced eHealth and Chat-Bot Enabled Delivery Model for Clinical Genetic Services in Community AYA Cancer Patients. ClinicalTrials.gov. NCT07091617. https://clinicaltrials.gov/study/NCT07091617
  2. 2.Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., Karlan, B. Y., Kohlmann, W., Kurian, A. W., Litton, J. K., Madlensky, L., Mankoff, D. A., Manley, S., Monteiro, A. N. A., Nathanson, K. L., ... Darlow, S. D. (2021). Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021. Journal of the National Comprehensive Cancer Network, 19(1), 77-102. https://doi.org/10.6004/jnccn.2021.0001
  3. 3.Keegan, T. H., Lichtensztajn, D. Y., Kato, I., Kent, E. E., Wu, X. C., West, M. M., Hamilton, A. S., Zebrack, B., Bellizzi, K. M., Smith, A. W., & AYA HOPE Study Collaborative Group. (2012). Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. Journal of Cancer Survivorship, 6(3), 239-250. https://doi.org/10.1007/s11764-012-0219-9
  4. 4.Robson, M., Im, S. A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., Wu, W., Goessl, C., Runswick, S., & Conte, P. (2017). Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. New England Journal of Medicine, 377(6), 523-533. https://doi.org/10.1056/NEJMoa1706450
  5. 5.Schwartz, D., & Lellouch, J. (2009). Explanatory and pragmatic attitudes in therapeutical trials. Journal of Clinical Epidemiology, 62(5), 499-505. https://doi.org/10.1016/j.jclinepi.2009.09.004
  6. 6.Yurgelun, M. B., & Hampel, H. (2018). Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. American Society of Clinical Oncology Educational Book, 38, 101-109. https://doi.org/10.1200/EDBK_200341
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service